-
EP1711184
European procedure
Extract from the Register of European Patents
EP About this file: EP1711184
| EP1711184 - (3-OXO-3,4-DIHYDRO-QUINOXALIN-2-YL-AMINO)-BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS GLYCOGEN PHOSPHORYLASE INHIBITORS FOR THE TREATMENT OF DIABETES AND OBESITY [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 23.05.2008 Database last updated on 31.08.2024 | Most recent event Tooltip | 23.05.2008 | No opposition filed within time limit | published on 25.06.2008 [2008/26] | Applicant(s) | For all designated states Janssen Pharmaceutica NV Turnhoutseweg 30 2340 Beerse / BE | [N/P] |
| Former [2006/42] | For all designated states JANSSEN PHARMACEUTICA N.V. Turnhoutseweg 30 2340 Beerse / BE | Inventor(s) | 01 /
BEAVERS, Mary, Pat 2581 Aquetong Road New Hope, Pennsylvania 18938 / US | 02 /
DUDASH, Joseph 51 Taurus Drive, Unit 1A Hillsborough, New Jersey 08844 / US | 03 /
ZHANG, Yongzheng 5 Stockton Road Hillsborough, New Jersey 08844 / US | [2006/42] | Representative(s) | Fisher, Adrian John, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2006/42] | Fisher, Adrian John, et al CARPMAELS & RANSFORD 43-45 Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 04815480.1 | 22.12.2004 | [2006/42] | WO2004US43409 | Priority number, date | US20040534534P | 06.01.2004 Original published format: US 534534 P | [2006/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005067932 | Date: | 28.07.2005 | Language: | EN | [2005/30] | Type: | A1 Application with search report | No.: | EP1711184 | Date: | 18.10.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.07.2005 takes the place of the publication of the European patent application. | [2006/42] | Type: | B1 Patent specification | No.: | EP1711184 | Date: | 18.07.2007 | Language: | EN | [2007/29] | Search report(s) | International search report - published on: | EP | 28.07.2005 | Classification | IPC: | A61K31/498, A61K31/4985, C07D413/12, C07D403/12, C07D417/12, C07D409/12, C07D407/12, C07D471/04, C07D241/44, A61P3/10 | [2006/42] | CPC: |
C07D405/12 (EP,US);
C07D241/44 (EP,KR,US);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/10 (EP);
C07D401/12 (EP,US);
C07D403/12 (EP,KR,US);
C07D409/12 (EP,US);
C07D413/12 (EP,KR,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/42] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | 26.06.2006 | LV | 26.06.2006 | MK | 26.06.2006 | YU | 26.06.2006 | Title | German: | (3-OXO-3,4-DIHYDRO-CHINOXALIN-2-YL-AMINO)-BENZAMID-DERIVATE UND VERWANDTE VERBINDUNGEN ALS GLYKOGEN-PHOSPHORYLASE-HEMMER ZUR BEHANDLUNG VON DIABETES UND ADIPOSITAS | [2006/42] | English: | (3-OXO-3,4-DIHYDRO-QUINOXALIN-2-YL-AMINO)-BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS GLYCOGEN PHOSPHORYLASE INHIBITORS FOR THE TREATMENT OF DIABETES AND OBESITY | [2006/42] | French: | DERIVES DE (3-OXO-3, 4-DIHYDRO-QUINOXALIN-2-YL-AMINO)-BENZAMIDE ET COMPOSES AFFERENTS COMME INHIBITEURS DE LA GLYCOGENE PHOSPHORYLASE DANS LE TRAITEMENT DU DIABETE ET DE L'OBESITE | [2006/42] | Entry into regional phase | 26.06.2006 | National basic fee paid | 26.06.2006 | Designation fee(s) paid | 26.06.2006 | Examination fee paid | Examination procedure | 26.06.2006 | Amendment by applicant (claims and/or description) | 26.06.2006 | Examination requested [2006/42] | 15.01.2007 | Communication of intention to grant the patent | 16.05.2007 | Fee for grant paid | 16.05.2007 | Fee for publishing/printing paid | Opposition(s) | 21.04.2008 | No opposition filed within time limit [2008/26] | Fees paid | Renewal fee | 26.06.2006 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO9509159 (OTSUKA PHARMA CO LTD [JP], et al) [A] 1-22* the whole document *; | [A]WO9946260 (ASTRA AB [SE], et al) [A] 1-22 * the whole document *; | [A]WO0042026 (NOVO NORDISK AS [DK], et al) [A] 1-22 * the whole document *; | [A]WO0123389 (NEUROGEN CORP [US], et al) [A] 1-22 * the whole document * |